Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The impact of air quality on cardiovascular health: A state of the art review.
Abdul-Rahman T, Roy P, Bliss ZSB, Mohammad A, Corriero AC, Patel NT, Wireko AA, Shaikh R, Faith OE, Arevalo-Rios ECE, Dupuis L, Ulusan S, Erbay MI, Cedeño MV, Sood A, Gupta R. Abdul-Rahman T, et al. Among authors: cedeno mv. Curr Probl Cardiol. 2024 Feb;49(2):102174. doi: 10.1016/j.cpcardiol.2023.102174. Epub 2023 Oct 30. Curr Probl Cardiol. 2024. PMID: 37913932 Review.
Role of mitochondria-bound HK2 in rheumatoid arthritis fibroblast-like synoviocytes.
Torres A, Kang S, Mahony CB, Cedeño M, Oliveira PG, Fernandez-Bustamante M, Kemble S, Laragione T, Gulko PS, Croft AP, Sanchez-Lopez E, Miyamoto S, Guma M. Torres A, et al. Among authors: cedeno m. Front Immunol. 2023 Jul 17;14:1103231. doi: 10.3389/fimmu.2023.1103231. eCollection 2023. Front Immunol. 2023. PMID: 37529037 Free PMC article.
Galectin-1, a novel promising target for outcome prediction and treatment in SCLC.
Corral JM, Puerto-Nevado LD, Cedeño M, Río-Vilariño A, Mahillo-Fernández I, Galeano C, Baños N, García-Foncillas J, Dómine M, Cebrián A. Corral JM, et al. Among authors: cedeno m. Biomed Pharmacother. 2022 Dec;156:113987. doi: 10.1016/j.biopha.2022.113987. Epub 2022 Nov 8. Biomed Pharmacother. 2022. PMID: 36411654 Free article.
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication.
Miles D, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Campone M, Bondarenko I, Nowecki Z, Errihani H, Paluch-Shimon S, Wardley A, Merot JL, Trask P, du Toit Y, Pena-Murillo C, Revelant V, Klingbiel D, Bachelot T; PERUSE investigators. Miles D, et al. Ann Oncol. 2021 Oct;32(10):1245-1255. doi: 10.1016/j.annonc.2021.06.024. Epub 2021 Jul 2. Ann Oncol. 2021. PMID: 34224826 Free article. Clinical Trial.
50 results